You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API budesonide, glycopyrrolate, and formoterol fumarate

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing budesonide, glycopyrrolate, and formoterol fumarate

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
AstraZeneca Pharmaceuticals LP	BREZTRI	budesonide, glycopyrrolate, and formoterol fumarate	0310-4616	1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE	2030-05-28
AstraZeneca Pharmaceuticals LP	BREZTRI	budesonide, glycopyrrolate, and formoterol fumarate	0310-4616	CALCIUM CHLORIDE	2030-05-28
AstraZeneca Pharmaceuticals LP	BREZTRI	budesonide, glycopyrrolate, and formoterol fumarate	0310-4616	NORFLURANE	2030-05-28
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for budesonide, glycopyrrolate, and formoterol fumarate

Excipient focus: 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE

budesonide, glycopyrrolate, and formoterol fumarate drug variants containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
AstraZeneca Pharmaceuticals LP	budesonide, glycopyrrolate, and formoterol fumarate	0310-4616
>Company	>Ingredient	>NDC

budesonide, glycopyrrolate, and formoterol fumarate drug variants not containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CALCIUM CHLORIDE

budesonide, glycopyrrolate, and formoterol fumarate drug variants containing CALCIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
AstraZeneca Pharmaceuticals LP	budesonide, glycopyrrolate, and formoterol fumarate	0310-4616
>Company	>Ingredient	>NDC

budesonide, glycopyrrolate, and formoterol fumarate drug variants not containing CALCIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: NORFLURANE

budesonide, glycopyrrolate, and formoterol fumarate drug variants containing NORFLURANE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
AstraZeneca Pharmaceuticals LP	budesonide, glycopyrrolate, and formoterol fumarate	0310-4616
>Company	>Ingredient	>NDC

budesonide, glycopyrrolate, and formoterol fumarate drug variants not containing NORFLURANE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.